ClinicalTrials.govpublic full text
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2
neoplasms, nsclc, feladilimab, iplimumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 811995
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.